iiinova — where your digital self keeps evolving

Invivyd @invivyd.bsky.social · 28/06/2025

Summer can be full of risks for the immunocompromised, heatwaves and possible #COVID19 surges, too. Are you an organ transplant recipient? Before heading indoors, you should know there are more COVID-19 protection tools than just vaccines. Learn more: expandtheiroptions.com #summersurge

010

Invivyd @invivyd.bsky.social · 31/05/2025

Are you at ASCO and need a quick, very entertaining break? Head on over to Out of Patients with Matthew Zachary, and listen to No One Told Me?! COVID and Cancer! @ascocancer.bsky.social @matthewzachary.bsky.social www.outofpatients.com/bonus-no-one...

outofpatients.com

021

Invivyd @invivyd.bsky.social · 28/05/2025

Results from our landmark Phase 3 CANOPY trial are now published in Clinical Infectious Diseases. This marks meaningful progress in protecting vulnerable populations and shows our commitment to gold-standard science. We extend our sincere thanks to everyone involved. 🔗 Learn more: lnkd.in/eB-E3N2X

000

Invivyd @invivyd.bsky.social · 12/05/2025

Earlier today, we announced a new pipeline discovery program focused on monoclonal antibody treatment for measles. Learn more: investors.invivyd.com/news-release... #measles

000

Invivyd @invivyd.bsky.social · 21/04/2025

Invivyd's Chief Scientific Officer Robert Allen will be speaking at The World Vaccine Congress today as part of the Optimizing mAbs for Infectious Diseases workshop. Dr. Allen will also be participating on a keynote panel on 4/23 entitled "Prophylactic mAbs - coming of age." #WVCDC

000

Invivyd @invivyd.bsky.social · 20/04/2025

Vaccines can only take us so far. Invivyd science breaks through biological limits to take us farther. #covid19 #monoclonalantibody #mAb #mAbs

010

Invivyd @invivyd.bsky.social · 19/04/2025

#ICYMI Catch the recent episode of The Sick Times “Still Here” podcast where Invivyd’s Chairman Marc Elia speaks with co-host Miles Griffis about the role of monoclonal antibodies in the ongoing #covid endemic. thesicktimes.org/2025/02/14/i... #covid19 #LongCovid

000

Invivyd @invivyd.bsky.social · 18/04/2025

#DidYouKnow? COVID-19 can cause vascular, systemic, thrombotic disease that damages every organ system. The best way to prevent long-term damage is to protect yourself from COVID-19. Don’t wait, visit www.expandtheiroptions.com for more information. #Covid19 #commonnotacold

010

Invivyd @invivyd.bsky.social · 17/04/2025

We’re thrilled to team up with Coach Jim Harbaugh to raise awareness about COVID-19 options for those who are immunocompromised. There are options. If you or someone you care about is immunocompromised, click here now: bit.ly/3EqqpUT

010

Invivyd @invivyd.bsky.social · 16/04/2025

April is Primary Immunodeficiency Month, a time to raise awareness about the more than 400 types of primary immunodeficiency disorders (PIDD). At Invivyd, we stand with the Primary Immunodeficiency community, many of whom may be vulnerable to the short-term and long-term impacts of COVID-19. 💙

000

Invivyd @invivyd.bsky.social · 12/04/2025

We are thrilled to be at @escmid.bsky.social presenting a poster on the structure of VYD2311 & in vitro neutralisation against a panel of contemporary SARS-CoV-2 variants. #ESCMIDGlobal #mAbs #covid

130

Invivyd @invivyd.bsky.social · 11/04/2025

💙🌿 Today marks National Living Donor Day and National Donate Life Blue and Green Day – days to honor those who selflessly donate life and give the gift of hope. At Invivyd, we are inspired by the courage and generosity of donors who make a lasting impact on the patients we serve. #BlueGreenDay

000

Invivyd @invivyd.bsky.social · 05/04/2025

We are thrilled to be at the 2025 Gulf Coast Hematology and Oncology Summit in Alabama! It is a privilege to meet colleagues who join us in their dedication to serve those living with cancer. #covid19 #cancer #oncology #hematology

000